This evidence-based clinical practice guideline (CPG) from the American Academy of Orthopaedic Surgeons (AAOS) outlines recommendations and a summary of options to manage rotator cuff injuries.

This evidence-based clinical practice guideline (CPG) from the American Academy of Orthopaedic Surgeons (AAOS) outlines recommendations and a summary of consensus statements to manage glenohumeral joint osteoarthritis.

This evidence-based clinical practice guideline (CPG) from the American Academy of Orthopaedic Surgeons (AAOS) outlines recommendations and a summary of options to manage carpal tunnel syndrome.

This evidence-based clinical practice guideline (CPG) from the American Academy of Orthopaedic Surgeons (AAOS) outlines recommendations and a summary of options to manage meniscal pathology.

This evidence-based clinical practice guideline (CPG) from the American Academy of Orthopaedic Surgeons (AAOS) outlines recommendations and a summary of consensus statements to manage knee osteoarthritis without arthroplasty.

This technology overview from the American Academy of Orthopaedic Surgeons (AAOS) summarizes the findings of studies published as of March 14, 2021, on the use of concentrated bone marrow aspirate for the treatment of knee osteoarthritis.

This technology overview from the American Academy of Orthopaedic Surgeons (AAOS) summarizes the findings of studies published as of August 25, 2021, on the use of platelet-rich plasma for the treatment of knee osteoarthritis.

This consensus from the European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA) and the International Cartilage Regeneration and Joint Preservation Society (ICRS) aimed to develop evidence- and expert-based, patient-focused recommendations on the appropriateness of intra-articular platelet-rich plasma (PRP) injections in different clinical scenarios for patients with knee osteoarthritis.

This state-of-the-art review by the International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS) explores the latest findings on platelet-rich plasma (PRP) efficacy in several musculoskeletal conditions, focusing on results of the highest level of evidence available.

This 2020 NBA Orthobiologics Consensus Statement provides a concise summary of available literature and practical clinical guidelines for team physicians and players.

This scientific update highlights clinical publications with positive, neutral, and negative outcomes associated with the use of the Angel® concentrated platelet-rich plasma (cPRP) system for the treatment of knee osteoarthritis (OA).

This scientific update highlights clinical publications with positive, neutral, and negative outcomes associated with the use of the Arthrex ACP® platelet-rich plasma (PRP) system for the treatment of knee osteoarthritis (OA).

The American Medical Society for Sports Medicine (AMSSM) prepared an educational toolkit that includes collective observations from physician experts in sports medicine education, as well as literature reviews of peer-reviewed articles regarding orthobiologic therapies including platelet-rich plasma, bone marrow aspirate concentrate, and microfragmented adipose tissue.

‍

The European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA) aimed to create a consensus statement to promote the responsible use of orthobiologics in clinical practice according to current knowledge and expert opinion by defining clear indications, as well as improved assessment and monitoring recommendations for a variety of orthobiologic therapies for the treatment of knee osteoarthritis, specifically focusing on cell-based treatment options (ie, bone marrow aspirate concentrate, microfragmented adipose tissue, and in vitro expanded mesenchymal stem cells).

The American Academy of Physical Medicine and Rehabilitation (AAPM&R) convened a technical expert panel (TEP) to summarize and assess the evidence for use of platelet-rich plasma (PRP) in patients with knee OA and synthesize current knowledge into a summary document that can serve as a resource for clinicians. The objective of this statement is to develop consensus-based practice recommendations and to identify and address gaps in PRP applications in patients with knee OA.